CHEBI:66919 - ruxolitinib

ChEBI IDCHEBI:66919
ChEBI Nameruxolitinib
Stars
DefinitionA pyrazole substituted at position 1 by a 2-cyano-1-cyclopentylethyl group and at position 3 by a pyrrolo[2,3-d]pyrimidin-4-yl group. Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.
Last Modified22 February 2017
SubmitterSteve
DownloadsMolfile
FormulaC17H18N6
Net Charge0
Average Mass306.373
Monoisotopic Mass306.15929
SMILESN#CC[C@H](C1CCCC1)n1cc(-c2ncnc3nccc23)cn1
InChIInChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1
InChIKeyHFNKQEVNSGCOJV-OAHLLOKOSA-N
Wikipedia
Roles Classification
Biological Roles:
anti-HIV agent  An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus.
antiviral agent  A substance that destroys or inhibits replication of viruses.
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor  An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2).
immunosuppressive agent  An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
antimicrobial agent  A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
Applications:
antirheumatic drug  A drug used to treat rheumatoid arthritis.
antifibrotic agent  Any agent which acts to reduce fibrosis.
immunosuppressive agent  An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
anti-anaemic agent  A compound which increases either the number of red cells or the amount of haemoglobin in the blood.
antipsoriatic  A drug used to treat psoriasis.
dermatologic drug  A drug used to treat or prevent skin disorders or for the routine care of skin.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
ChEBI Ontology
Outgoing Relation(s)
ruxolitinib (CHEBI:66919) has role anti-anaemic agent (CHEBI:75835)
ruxolitinib (CHEBI:66919) has role anti-HIV agent (CHEBI:64946)
ruxolitinib (CHEBI:66919) has role antifibrotic agent (CHEBI:233423)
ruxolitinib (CHEBI:66919) has role antimicrobial agent (CHEBI:33281)
ruxolitinib (CHEBI:66919) has role antineoplastic agent (CHEBI:35610)
ruxolitinib (CHEBI:66919) has role antipsoriatic (CHEBI:50748)
ruxolitinib (CHEBI:66919) has role antirheumatic drug (CHEBI:35842)
ruxolitinib (CHEBI:66919) has role antiviral agent (CHEBI:22587)
ruxolitinib (CHEBI:66919) has role dermatologic drug (CHEBI:50177)
ruxolitinib (CHEBI:66919) has role EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor (CHEBI:76617)
ruxolitinib (CHEBI:66919) has role immunosuppressive agent (CHEBI:35705)
ruxolitinib (CHEBI:66919) is a nitrile (CHEBI:18379)
ruxolitinib (CHEBI:66919) is a pyrazoles (CHEBI:26410)
ruxolitinib (CHEBI:66919) is a pyrrolopyrimidine (CHEBI:38670)
Incoming Relation(s)
ruxolitinib phosphate (CHEBI:66917) has part ruxolitinib (CHEBI:66919)
IUPAC Name 
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
INN  Source
ruxolitinibKEGG DRUG
Synonyms  Source
INC-424ChEMBL
INC424ChEMBL
INCB-018424ChEMBL
INCB018424ChemIDplus
INCB-18424ChEMBL
Ruxolitinib, s-ChEMBL
Manual XrefsDatabases
4190DrugCentral
D09959KEGG DRUG
LSM-1139LINCS
RuxolitinibWikipedia
US2008312258Patent
US2010190981Patent
Registry NumbersSources
Reaxys:18703668Reaxys
CAS:941678-49-5KEGG DRUG
CAS:941678-49-5ChemIDplus
Citations